Pseudomonas aeruginosa Evolutionary Adaptation and Diversification in Cystic Fibrosis Chronic Lung Infections
about
Neutrophil plasticity enables the development of pathological microenvironments: implications for cystic fibrosis airway diseaseEvolutionary diversification of Pseudomonas aeruginosa in an artificial sputum modelAchromobacter xylosoxidans infection in cystic fibrosis siblings with different outcomes: Case reportsGenomics of antibiotic-resistance prediction in Pseudomonas aeruginosa.Evolution, genomics and epidemiology of Pseudomonas syringae: Challenges in Bacterial Molecular Plant Pathology.Evolution of the Pseudomonas aeruginosa mutational resistome in an international Cystic Fibrosis cloneWithin-Host Evolution of the Dutch High-Prevalent Pseudomonas aeruginosa Clone ST406 during Chronic Colonization of a Patient with Cystic Fibrosis.High virulence sub-populations in Pseudomonas aeruginosa long-term cystic fibrosis airway infections.Temperate phages both mediate and drive adaptive evolution in pathogen biofilms.Pseudomonas aeruginosa Lifestyle: A Paradigm for Adaptation, Survival, and Persistence.Regulation of neutrophil functions through inhibitory receptors: an emerging paradigm in health and disease.Acquisition and adaptation of the airway microbiota in the early life of cystic fibrosis patients.Pseudomonas aeruginosa adaptation and diversification in the non-cystic fibrosis bronchiectasis lung.In the Shadow of Fibrosis: Innate Immune Suppression Mediated by Transforming Growth Factor-β.Siderophores in Iron Metabolism: From Mechanism to Therapy Potential.Targeting the hard to reach: challenges and novel strategies in the treatment of intracellular bacterial infections.Inflammation: A Double-Edged Sword in the Response to Pseudomonas aeruginosa Infection.Environmental and genetic modulation of the phenotypic expression of antibiotic resistance.Clinical implications of Pseudomonas aeruginosa location in the lungs of patients with cystic fibrosis.Understanding the Entanglement: Neutrophil Extracellular Traps (NETs) in Cystic FibrosisNonribosomal peptide synthetase biosynthetic clusters of ESKAPE pathogens.Immunogenicity and antimicrobial effectiveness of Pseudomonas aeruginosa specific bacteriophage in a human lung in vitro model.The role of multispecies social interactions in shaping Pseudomonas aeruginosa pathogenicity in the cystic fibrosis lung.Recent advances in understanding Pseudomonas aeruginosa as a pathogen.Two-component systems required for virulence in Pseudomonas aeruginosa.Quorum Sensing Attenuates Virulence in Sodalis praecaptivus.An update on the pharmacotherapeutic management of lower respiratory tract infections.Pseudomonas aeruginosa-Derived Rhamnolipids and Other Detergents Modulate Colony Morphotype and Motility in the Burkholderia cepacia Complex.Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection.Impact of High Diversity of Achromobacter Populations within Cystic Fibrosis Sputum Samples on Antimicrobial Susceptibility Testing.Human Tear Fluid Reduces Culturability of Contact Lens-Associated Pseudomonas aeruginosa Biofilms but Induces Expression of the Virulence-Associated Type III Secretion System.Molecular Epidemiology of Mutations in Antimicrobial Resistance Loci of Pseudomonas aeruginosa Isolates from Airways of Cystic Fibrosis Patients.Cystic Fibrosis Isolates of Pseudomonas aeruginosa Retain Iron-Regulated Antimicrobial Activity against Staphylococcus aureus through the Action of Multiple Alkylquinolones.Draft Genome Sequences of 10 Environmental Pseudomonas aeruginosa Strains Isolated from Soils, Sediments, and Waters.The Semi-Synthetic Peptide Lin-SB056-1 in Combination with EDTA Exerts Strong Antimicrobial and Antibiofilm Activity against Pseudomonas aeruginosa in Conditions Mimicking Cystic Fibrosis Sputum.Individual Patterns of Complexity in Cystic Fibrosis Lung Microbiota, Including Predator Bacteria, over a 1-Year PeriodCombining Comprehensive Analysis of Off-Site Lambda Phage Integration with a CRISPR-Based Means of Characterizing Downstream Physiology.Comparative Genome Analyses of Vibrio anguillarum Strains Reveal a Link with Pathogenicity Traits.Highly Diversified Pandoraea pulmonicola Population during Chronic Colonization in Cystic Fibrosis.Changes in the lung bacteriome in relation to antipseudomonal therapy in children with cystic fibrosis.
P2860
Q28071357-8EFD903A-D07B-437E-B61E-2A4F11CE92E8Q28359832-D68F9F8F-0B28-49B1-BA54-73F8A27F896CQ28818541-4A95DDA6-9062-4687-9E79-54CC42D8DA90Q30234118-ADAD16CF-6EC8-4705-9BED-C470F4CFC1D7Q30243898-27F995AC-3AE2-4F72-84E0-8DC6426DBDCEQ33911762-3F8969E0-8F5D-4721-922B-80C499B975C8Q36060289-33086E7D-B902-4430-B5C6-C528FBE15D74Q36270239-69F4A7A3-9D9D-4375-A58F-FBD96939CBF1Q37126836-9A8DA04C-303E-4EFB-AC52-55ABA05EA474Q37643058-09DB6B7E-3F9D-46CE-AA82-48A9BE097926Q38377860-65084A62-CBE3-416B-9A4D-8CF703EA8B2BQ38769187-DE37F3CA-8B89-4745-9D8F-945B83C648B7Q38818065-CF758C04-1D7B-49AF-9E4D-71C73C6B7053Q38948397-756E3692-6631-4721-9C6D-0AD16D7636A0Q39003164-D8689B11-D9A1-408D-9666-D6E560ECB07BQ39031276-959F26D0-1668-49C6-BB2D-BCF8D272A28DQ39145412-CA82CFED-6E57-4433-8229-7565A55191EEQ39195574-20727B14-3D67-449D-8BEF-2A90FA52C31CQ39218303-B5AB8B87-D589-4660-864E-AA2842FAE1A0Q39253846-0E9B7DD2-621B-485B-8A1B-1FC0C4C03802Q39392982-1B2347A3-3195-4F9F-A640-4A175C336781Q40044171-F6DD4E46-41B1-4B2F-A55E-B41A2924E64CQ40062783-D37950EE-B475-42DE-827A-061FAF8E8D25Q40099481-5274D998-BC29-4F60-B495-4FA5568D25D9Q40210470-11A2CA98-6F8C-4354-AAD8-11921BAE7D1AQ40216967-AEA0803A-9FB4-4BBD-9E12-710FE4A97BBBQ40222424-621E8D65-E19F-4BC5-902C-9ACA6051B152Q40239225-27387286-A999-44F1-A8CD-EA2B72CA76F5Q40245763-EB3CED29-AA38-432D-8D96-538B8C338784Q40468493-7F71E79E-0DB7-425D-9538-D4EA51C560CCQ40527067-86462146-CA98-435A-8544-5F538E468044Q40559371-984CEE54-9865-4DBE-9970-FA5AFE107363Q40580336-7B66FB3F-AFFF-4C81-971A-D149EC79D8CAQ41519503-D1A8A6D9-9DC5-4E46-91C8-01CDD1B63A45Q41660396-527ACE65-AEA8-41F5-B33E-52DFAD6B585EQ41676206-15D77DF8-BD28-404B-874B-A58373F96C5BQ41676286-3B1DF62C-787D-415C-98B4-4B6E0745D360Q42316905-3A6E8EF6-BB5A-4B88-891A-847DFE9B6303Q43071756-48C08308-846A-47A4-8808-1B556CEBB5E8Q46263483-9FEF09CA-EFD4-48B2-9439-14C0613E038B
P2860
Pseudomonas aeruginosa Evolutionary Adaptation and Diversification in Cystic Fibrosis Chronic Lung Infections
description
2016 nî lūn-bûn
@nan
2016 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
Pseudomonas aeruginosa Evoluti ...... brosis Chronic Lung Infections
@ast
Pseudomonas aeruginosa Evoluti ...... brosis Chronic Lung Infections
@en
Pseudomonas aeruginosa Evoluti ...... brosis Chronic Lung Infections
@nl
type
label
Pseudomonas aeruginosa Evoluti ...... brosis Chronic Lung Infections
@ast
Pseudomonas aeruginosa Evoluti ...... brosis Chronic Lung Infections
@en
Pseudomonas aeruginosa Evoluti ...... brosis Chronic Lung Infections
@nl
prefLabel
Pseudomonas aeruginosa Evoluti ...... brosis Chronic Lung Infections
@ast
Pseudomonas aeruginosa Evoluti ...... brosis Chronic Lung Infections
@en
Pseudomonas aeruginosa Evoluti ...... brosis Chronic Lung Infections
@nl
P2093
P2860
P50
P921
P3181
P1476
Pseudomonas aeruginosa Evoluti ...... brosis Chronic Lung Infections
@en
P2093
Craig Winstanley
Michael A Brockhurst
Siobhan O'Brien
P2860
P304
P3181
P356
10.1016/J.TIM.2016.01.008
P407
P5008
P577
2016-05-01T00:00:00Z